Table 1

Comparison of Saudi and Pakistani subjects with diabetes’ demographics, medications and biochemical parameters (frequency, percentage and p value)

CharacteristicsSaudi, N (%)Pakistani, N (%)P value
Age groups (years)
 20–29.949 (24)7 (3.4)<0.001*
 30–39.930 (14.7)60 (29.9)
 40–49.928 (13.7)64 (31.8)
 50–59.947 (23)51 (25.4)
 >6050 (24.5)19 (9.5)
Gender
 Female81 (39.7)83 (41.3)0.745
 Male123 (60.3)118 (58.7)
Diabetes type
 Type 164 (31.4)16 (8)<0.001*
 Type 2140 (68.6)185 (92)
Duration of diabetes (years)
 <564 (31.3)90 (44.8)<0.001*
 5–9.952 (25.5)67 (33.3)
 10–14.935 (17.2)24 (11.9)
 15–19.920 (9.8)12 (6)
 >2033 (16.2)8 (4)
Medication
 Insulin48 (23.5)25 (12.4)0.001*
 Tablets131 (64.2)129 (64.2)
 Tablets and insulin both25 (12.3)47 (23.4)
FPG (mmol/L)
 <5.652 (25.5)31 (15.5)0.032*
 5.6–7.0102 (50)107 (52.2)
 >750 (24.5)63 (31.3)
HbA1c (%)
 <6.589 (43.6)105 (52.2)0.083
 >6.5115 (56.4)96 (47.8)
Cholesterol (mmol/L)
 <5.18135 (66.2)139 (69.2)0.432
 >5.1869 (33.8)62 (30.8)
Triglycerides (mmol/L)
 <1.7121 (59.3)149 (74.1)0.002*
 >1.783 (40.7)52 (25.9)
  • *Significant p value.

  • FPG, fasting plasma glucose; HbA1c, glycated haemoglobin.